Despite drop in Q3 revenue due to slowing Covid-19 testing, Labcorp advances strategic partnerships and spinoff


As Covid-19 testing slows, Labcorp reported an 11% decrease in revenue during the third quarter of 2022, down to $3.6 billion. Yet, the company progressed several strategic acquisitions, such as its relationships with Ascension and RWJBarnabas Health.

Previous CEO Jennifer Byrne: Javara remains committed to keeping headquarters in Winston-Salem as company prepares to rapidly hire and expand
Next Women's health care group in Tampa names new CEO